The Digoxin Capsules, cataloged under National Stock Number 6505-01-210-5887, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 5 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-210-5887 |
| Item Name | Digoxin Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 30.000 |
| Capsule Type | SOFT |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 0.100 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| NDC00081-0272-30 | 3/9 Design control — primary reference Burroughs Wellcome Co |
| 0081-0272-230 | 5/9 Secondary reference Burroughs Wellcome Co |
| LANOXICAPS | 5/9 Secondary reference Burroughs Wellcome Co |
NSN 6505-01-210-5887 is a Digoxin Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-210-5887: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 30.000; Capsule Type: SOFT; Capsule Content Form: POWDER. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.